152 related articles for article (PubMed ID: 388470)
21. Effect of sulphated polysaccharides on prostacyclin (prostaglandin I2)-induced inhibition of platelet aggregation [proceedings].
Kindness G; Williamson FB; Long WF
Biochem Soc Trans; 1980 Jun; 8(3):377-9. PubMed ID: 6995209
[No Abstract] [Full Text] [Related]
22. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
Ubatuba FB; Moncada S; Vane JR
Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
[TBL] [Abstract][Full Text] [Related]
23. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
[TBL] [Abstract][Full Text] [Related]
24. De-aggregatory action of prostacyclin in vivo and its enhancement by theophylline.
Gryglewski RJ; Korbut R; Ocetkiewicz A
Prostaglandins; 1978 Apr; 15(4):637-44. PubMed ID: 353903
[TBL] [Abstract][Full Text] [Related]
25. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
Salvemini D; de Nucci G; Vane JR
Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
[TBL] [Abstract][Full Text] [Related]
26. The use of prostacyclin, PGI2, in the prevention of platelet aggregation during charcoal haemoperfusion.
Langley PG; Hughes RD; Ton HY; Silk DB; Williams R
Int J Artif Organs; 1979 Jul; 2(4):207-10. PubMed ID: 378864
[TBL] [Abstract][Full Text] [Related]
27. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
Briel RC; Lippert TH
Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
[TBL] [Abstract][Full Text] [Related]
28. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
[TBL] [Abstract][Full Text] [Related]
29. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.
Rao GH; Reddy KR; White JG
Prostaglandins Med; 1980 Jun; 4(6):385-97. PubMed ID: 6251492
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
31. Mechanism of action of dipyridamole.
Harker LA; Kadatz RA
Thromb Res Suppl; 1983; 4():39-46. PubMed ID: 6356465
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
Karim SM; Adaikan PG; Lau LC; Tai MY
Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
[TBL] [Abstract][Full Text] [Related]
33. In vitro inhibition by endotoxin of the anti-aggregatory action of prostacyclin produced by aortic rings.
Bult H; Herman AG
Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):335-6. PubMed ID: 361006
[No Abstract] [Full Text] [Related]
34. Ingestion of dipyridamole reduces inhibitory effect of prostacyclin on human platelets.
Di Minno G; Silver MJ; De Gaetano G
Lancet; 1979 Sep; 2(8144):701-2. PubMed ID: 90798
[No Abstract] [Full Text] [Related]
35. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
36. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
37. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
Ehrman ML; Jaffe EA
Prostaglandins; 1980 Dec; 20(6):1103-16. PubMed ID: 7010448
[TBL] [Abstract][Full Text] [Related]
38. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
[No Abstract] [Full Text] [Related]
39. Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.
Schafer AI; Zavoico GB; Loscalzo J; Maas AK
Blood; 1987 May; 69(5):1504-7. PubMed ID: 3032310
[TBL] [Abstract][Full Text] [Related]
40. Platelet interactions with the endothelium and the subendothelium: the role of thrombin and prostacyclin.
Cazenave JP; Dejana E; Kinlough-Rathbone R; Packham MA; Mustard JF
Haemostasis; 1979; 8(3-5):183-92. PubMed ID: 389756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
